- Toyokuni, S. (1996) "Iron-induced carcinogenesis: the role of redox regulation", Free Radical Biology and Medicine 20, 553-566.
- Drapier, J.C., Pellat, C. and Henry, Y. (1991) "Generation of EPR-detectable nitrosyl-iron complexes in tumor target cells cocultured with activated macrophages", Journal of Biological Chemistry 266, 10162-10167.
- Bastian, N.R., Yim, C.Y., Hibbs, J.B. and Samlowski, W.E. (1994) "Induction of iron-derived EPR signals in murine cancers by nitric oxide. Evidence for multiple intracellular targets", Journal of Biological Chemistry 269, 5127-5131.
- Feger, F., Ferry-Dumazet, H., Mamani Matsuda, M., Bordenave, J., Dupouy, M., Nussler, A.K., Arock, M., Devevey, L., Nafziger, J., Guillosson, J.J., Reiffers, J. and Mossalayi, D. (2001) "Role of iron in tumor cell protection from the proapoptosic effect of nitric oxide", Cancer Research 61, 5289-5294
- Daley, G.Q. and Ben Neriah, Y. (1991) "Implicating the bcr/abl gene in the pathogenesis of Philadelphia chromosome-positive human leukemia", Advances in Cancer Research 57, 151-184.
- Abalea, V., Cillard, J., Dubos, M.P, Anger, J.P., Cillard, P. and Morel, I. (1998) "Iron-induced oxidative DNA damage and its repair in primary rat hepatocyte culture", Carcinogenesis 19, 1053-1059.
- Ferry-Dumazet, H., Mamani-Matsuda, M., Dupouy, M., Belloc, F., Thiolat, D., Marit, G., Arock, M., Reiffers, J. and Mossalayi, M.D. (2002) "Nitric oxide induces the apoptosis of human BCR-ABL-positive myeloid leukemia cells: Evidence for the chelation of intracellular iron", Leukemia 16, 708-715.
- Darnell, G. and Richardson, D.R. (1999) "The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III: the effect of the ligands on molecular targets involved in proliferation", Blood 94, 781-792.
- Liu, Z.D. and Hider, R.C. (2002) "Design of clinically useful iron(III)-selective chelators", Medicinal Research Reviews 22, 26-64.
- Addis, A., Loebstein, R., Koren, G. and Einarson, T.R. (1999) "Meta-analytic review of the clinical effectiveness of oral deferiprone", European Journal of Clinical Pharmacology 55, 1-6.
- Rai, B.L., Dekhordi, L.S., Khodr, H., Jin, Y., Liu, Z. and Hider, R.C. (1998) "Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(lH)-pyridinones", Journal of Medicinal Chemistry 41, 3347-3359.
- Liu, Z.D., Lockwood, M., Rose, S., Theobald, A.E. and Hider, R.C. (2001) "Structure-activity investigation of the inhibition of 3-hydroxypyridin-4-ones on mammalian tyrosine hydroxylase", Biochemical Pharmacology 61, 285-290.
- Sirard, C., Laneuville, P. and Dick, J.E. (1994) "Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism", Blood 83, 1575-1585.
- Bosc, J.J., Jarry, C., Carpy, A., Panconi, E. and Descas, P. (1992) "Synthesis and antidepressant activity of 5-(l-aryl-4-piperazino)methyl-2-amino-2-oxazolines", European Journal of Medicinal Chemistry 27, 437-442.
- Le Berre, A. and Renault, C. (1969) "Pyrrolo[l,2-a]pyrimidines. I.-Condensation de l'amino-2 ?-l pyrroline avec les esters maloniques", Bulletin de la Société Chimique de France 9, 3133-3138.
- Allen, F.H., Kennard, O., Watson, D.G., Brammer, L., Orpen, A.G. and Taylor, R. (1987) "Tables of bonds lengths determined by X-ray and neutron diffraction Part 1. Bond lengths in organic compounds", Journal of the Chemical Society, Perkin Transactions II, S1-S18.
- Ferrali, M., Donati, D., Bambagioni, S., Fontani, M., Giorgi, G. and Pietrangelo, A. (2001) "3-Hydroxy(4H)-benzopyran-4-ones as potential iron chelating agents in vivo", Bioorganic and Medicinal Chemistry 9, 3041-3047.
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 17, 2002 - Issue 6